Yagi Sen, Furukawa Shinya, Tange Kazuhiro, Ninomiya Tomoyuki, Suzuki Seiyuu, Ohashi Katsuhisa, Yamamoto Yasunori, Takeshita Eiji, Ikeda Yoshio, Hiasa Yoichi
Department of Internal Medicine, Saiseikai Imabari Hospital, Imabari, JPN.
Health Services Center, Ehime University, Matsuyama, JPN.
Cureus. 2024 May 7;16(5):e59787. doi: 10.7759/cureus.59787. eCollection 2024 May.
Background The ABO blood type has been associated with several digestive diseases. Some evidence has shown an association between ABO blood type and clinical outcomes among Asian patients with Crohn's disease. However, there are no reports about the association between ABO blood type and clinical outcomes in ulcerative colitis (UC). In this study, we aimed to evaluate the association between ABO blood type and clinical characteristics among patients with UC. Methodology The study subjects consisted of 277 Japanese patients with UC. Information on clinical characteristics and ABO blood type data was collected using medical records and a self-reported questionnaire. The information on clinical remission was collected using medical records. The definition of mucosal healing (MH) and partial MH was Mayo endoscopic subscore of 0 or 0-1, respectively. Results Of the enrolled patients, 39.4% (109/277), 18.4% (51/277), 29.2% (81/277), and 13.0% (36/277) had blood types A, B, O, and AB, respectively. The mean current age, age at onset of UC, and body mass index were 51.3 years, 42.1 years, and 22.7 kg/m, and the proportion of male patients was 59.2% (164/277). The proportion of patients with clinical remission, MH, partial MH, and prednisolone use were 58.1% (161/277), 25.6% (71/277), 63.2% (175/277), and 21.3% (59/277), respectively. Conclusions None of the blood types were associated with any of the variables in this study. Among Japanese patients with UC, ABO blood type might not be associated with clinical characteristics.
ABO血型与多种消化系统疾病有关。一些证据表明,亚洲克罗恩病患者的ABO血型与临床结局之间存在关联。然而,尚无关于ABO血型与溃疡性结肠炎(UC)临床结局之间关联的报道。在本研究中,我们旨在评估UC患者ABO血型与临床特征之间的关联。
研究对象包括277例日本UC患者。使用病历和自我报告问卷收集临床特征和ABO血型数据信息。使用病历收集临床缓解信息。黏膜愈合(MH)和部分MH的定义分别为梅奥内镜亚评分为0或0 - 1。
在纳入的患者中,血型A、B、O和AB的患者分别占39.4%(109/277)、18.4%(51/277)、29.2%(81/277)和13.0%(36/277)。当前平均年龄、UC发病年龄和体重指数分别为51.3岁、42.1岁和22.7kg/m²,男性患者比例为59.2%(164/277)。临床缓解、MH、部分MH和使用泼尼松龙的患者比例分别为58.1%(161/277)、25.6%(71/277)、63.2%(175/277)和21.3%(59/277)。
本研究中没有任何一种血型与任何变量相关。在日本UC患者中,ABO血型可能与临床特征无关。